Table 2.
Characteristics of the COVID-19 positive and COVID-19 negative patients in the cohort.
| Total (n = 13,638) | Severe COVID-19 (n = 178) | Mild/Moderate COVID-19 (n = 246) | No COVID-19 (n = 13,214) | |
|---|---|---|---|---|
| No. (%) with data | ||||
| All-cause deaths | 2,686 (19.7%) | 93 (52.2%) | 39 (15.9%) | 2,554 (19.3%) |
| Cardiovascular deaths | 191 (1.4%) | 11 (6.2%) | 1 (0.04%) | 179 (1.4%) |
| Respiratory deaths | 181 (1.3%) | 13 (7.3%) | 2 (0.8%) | 166 (1.3%) |
| Male | 5,674 (41.6%) | 75 (42.1%) | 87 (35.4%) | 5,512 (41.7%) |
| Non-Hispanic White | 8,706 (63.8%) | 86 (48.3%) | 113 (45.9%) | 8,507 (64.4%) |
| Non-Hispanic Black | 3,379 (24.7%) | 76 (42.7%) | 80 (32.5%) | 3,223 (24.3%) |
| Hispanic | 764 (5.6%) | 5 (2.8%) | 32 (13.0%) | 727 (5.5%) |
| Age | ||||
| Under 65 | 8,801 (64.5%) | 81 (45.5%) | 196 (79.7%) | 8,524 (64.5%) |
| 65+ | 4,837 (35.5%) | 97 (54.5%) | 50 (20.3%) | 4,690 (35.5%) |
| Charlson Comorbidity Index score | 6,753 (49.5%) | 46 (25.8%) | 181 (73.6%) | 6,526 (49.4%) |
| 0–1 | ||||
| 2–3 | 2,856 (20.9%) | 48 (27.0%) | 23 (9.3%) | 2,980 (22.6%) |
| 4+ | 3,834 (28.1%) | 84 (47.2%) | 42 (17.1%) | 3,708 (28.1%) |